Epidemic of prescription opiate abuse and neonatal abstinence

JAMA

Volumn 307, Issue 18, 2012, Pages 1974-1975

  Hayes, Marie J ^a,b   Brown, Mark S ^b  

^a University of Maine   (United States)

^b EASTERN MAINE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; BUPRENORPHINE; CLONAZEPAM; CLONIDINE; METHADONE; MORPHINE; OPIATE;

CHILD HEALTH; CHILD HOSPITALIZATION; DISEASE SEVERITY; DRUG ABUSE PATTERN; DRUG DETOXIFICATION; DRUG EFFECT; DRUG EXPOSURE; DRUG MONITORING; EDITORIAL; EPIDEMIC; HUMAN; LENGTH OF STAY; METHADONE TREATMENT; OPIATE ADDICTION; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT DURATION; WITHDRAWAL SYNDROME;

EID: 84860777270     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.4526     Document Type: Editorial

References (20)

1. Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM.Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009 [published online April 30, 2012]. JAMA. 2012;307(18): 1934-1940.
2. Centers for Disease Control and Prevention. CDC Congressional Testimony, 2007. http://www.cdc.gov/washington/testimony/2007/t20071024.htm. Accessed April 16, 2012.
3. Paulozzi LJ, Xi Y. Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type. Pharmacoepidemiol Drug Saf. 2008; 17(10):997-1005.
4. Hunt RW, Tzioumi D, Collins E, Jeffery HE. Adverse neurodevelopmental outcome of infants exposed to opiate in-utero. Early Hum Dev. 2007;84(1):29-35.
5. Brown MS, Hayes MJ, LaBrie S. Breastfeeding is associated with decreased risk and length of treatment for neonatal abstinence syndrome in methadone and buprenorphine exposed infants. Presented at: Pediatric Academic Societies; May 1-4, 2011; Vancouver, British Columbia, Canada. Abstract 2917.228.
6. Dryden C, Young D, Hepburn M, Mactier H. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG. 2009;116(5):665-671.
7. Pritham UA, Paul JA, Hayes MJ. Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome. JObstet Gynecol Neonatal Nurs. 2012; 41(2):180-190.
8. Levinson-Castiel R, Merlob P, Linder N, Sirota L, Klinger G. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med. 2006;160(2):173-176. (Pubitemid 43213863)
9. Jansson LM, Dipietro JA, Elko A, Velez M. Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates. J Matern Fetal Neonatal Med. 2007;20(9):677-685. (Pubitemid 47262703)
10. Wachman EM, Newby PK, Vreeland J, et al. The relationship between maternal opioid agonists and psychiatric medications on length of hospitalization for neonatal abstinence syndrome. J Addict Med. 2011;5(4):293-299.
11. Lacroix-Fralish ML,Mogil JS. Progress in genetic studies of pain and analgesia. Annu Rev Pharmacol Toxicol. 2009;49:97-121.
12. Wachman EM, Brown MS, Paul JA, et al. Single nucleotide polymorphisms and variability in severity of neonatal abstinence syndrome. Presented at: Pediatric Academic Societies; April 28-May 1, 2012; Boston, MA.
13. Finnegan LP. Neonatal abstinence syndrome: assessment and pharmacotherapy. In: Rubatelli FF, Granati B, eds. Neonatal Therapy: An Update. New York, NY: Excerpta Medica; 1986:122-146.
14. Jones HE, Kaltenbach K, Heil SH, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363(24):2320-2331.
15. Salisbury AL, Ponder KL, Padbury JF, Lester BM. Fetal effects of psychoactive drugs. Clinics in Perinatology. 2009;36(3):595-619.
16. Office of Applied Studies, Substance Abuse and Mental Health Services Administration (SAMHSA). The Treatment Episode Data Set (TEDS). http://oas.samhsa .gov/dasis.htm#teds2. Accessed April 16, 2012.
17. Hayes MJ, Brown E, Hofmaster PA, Davare AA, Parker KG, Raczek JA. Prenatal alcohol intake in a rural, caucasian clinic. Fam Med. 2002;34(2):120- 125.
18. Logan BA, Hayes MJ, Brown M, et al. Maine's high risk infants and maternal health and wellbeing. Maine Policy Rev. 2009;18:60-67.
19. Messinger DS, Bauer CR, Das A, et al. The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age. Pediatrics. 2004;113(6):1677-1685. (Pubitemid 38697976)
20. Jansson LM, Choo R, Velez ML, et al. Methadone maintenance and breast-feeding in the neonatal period. Pediatrics. 2008;121(1):106-114.